This inventor holds 1 USPTO granted patent. Top assignees: Idemitsu Kosan Company, Limited, Nara Institute of Science and Technology, Obihiro University of Agriculture and Veterinary Medicine. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: The Innovative Contributions of Keiko Kawamoto
Introduction
Keiko Kawamoto is a prominent inventor based in Obihiro, Japan. She has made significant strides in the field of biotechnology, particularly in developing innovative solutions for agricultural and veterinary applications. Her work focuses on creating cost-effective vaccines using transgenic plants.
Latest Patents
One of her notable patents is titled "Transgenic plants expressing STX2EB protein for use as a pig edema disease vaccine." This technology aims to produce a pig edema disease vaccine at low cost and high efficiency. Specifically, it involves the efficient expression of a gene encoding the Stx2e protein, a toxin associated with pig edema disease, in plant cells. By utilizing the 5'-untranslated region of an alcohol dehydrogenase gene derived from plants, she has developed a method to produce a plant-based vaccine that can be manufactured economically.
Career Highlights
Throughout her career, Keiko has worked with reputable organizations, including Idemitsu Kosan Company, Limited and the Nara Institute of Science and Technology. Her contributions to these institutions have been instrumental in advancing research and development in her field.
Collaborations
Keiko has collaborated with notable colleagues such as Kazutoshi Sawada and Kazuya Yoshida. These partnerships have fostered innovation and have been crucial in the successful development of her projects.
Conclusion
Keiko Kawamoto's work exemplifies the intersection of biotechnology and agriculture, showcasing her commitment to improving animal health through innovative solutions. Her contributions continue to impact the field positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile